Tags

Type your tag names separated by a space and hit enter

Powering a prospective melanoma chemoprevention trial in high-risk cohorts.
Int J Dermatol 2019; 58(11):e232-e234IJ

Authors+Show Affiliations

Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA.Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA.Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA. Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA. Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA. Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.

Pub Type(s)

Letter

Language

eng

PubMed ID

31206619

Citation

Varedi, Amir, et al. "Powering a Prospective Melanoma Chemoprevention Trial in High-risk Cohorts." International Journal of Dermatology, vol. 58, no. 11, 2019, pp. e232-e234.
Varedi A, Bishop MD, Boucher KM, et al. Powering a prospective melanoma chemoprevention trial in high-risk cohorts. Int J Dermatol. 2019;58(11):e232-e234.
Varedi, A., Bishop, M. D., Boucher, K. M., Kim, C. C., & Grossman, D. (2019). Powering a prospective melanoma chemoprevention trial in high-risk cohorts. International Journal of Dermatology, 58(11), pp. e232-e234. doi:10.1111/ijd.14538.
Varedi A, et al. Powering a Prospective Melanoma Chemoprevention Trial in High-risk Cohorts. Int J Dermatol. 2019;58(11):e232-e234. PubMed PMID: 31206619.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Powering a prospective melanoma chemoprevention trial in high-risk cohorts. AU - Varedi,Amir, AU - Bishop,Michael D, AU - Boucher,Kenneth M, AU - Kim,Caroline C, AU - Grossman,Douglas, Y1 - 2019/06/17/ PY - 2019/03/04/received PY - 2019/04/18/revised PY - 2019/05/20/accepted PY - 2019/6/18/pubmed PY - 2019/6/18/medline PY - 2019/6/18/entrez SP - e232 EP - e234 JF - International journal of dermatology JO - Int. J. Dermatol. VL - 58 IS - 11 SN - 1365-4632 UR - https://www.unboundmedicine.com/medline/citation/31206619/Powering_a_prospective_melanoma_chemoprevention_trial_in_high-risk_cohorts L2 - https://doi.org/10.1111/ijd.14538 DB - PRIME DP - Unbound Medicine ER -